Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk.
Frontiers in immunology
View this publicationFrontiers in immunology
View this publicationMed (New York, N.Y.)
View this publicationThe Lancet. Infectious diseases
View this publicationClinical infectious diseases : an official publication of the Infectious Diseases Society of America
View this publicationGenome medicine
View this publicationPhysiological reviews
View this publicationFrontiers in immunology
View this publicationScience advances
View this publicationPublication categories: Top publication
Nature
View this publicationFrontiers in immunology
View this publication